Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) EBT (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of EBT readings, the most recent being $505.0 million for Q1 2026.

  • On a quarterly basis, EBT fell 27.02% to $505.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.6 billion, a 6.52% decrease, with the full-year FY2025 number at $2.8 billion, up 7.25% from a year prior.
  • EBT hit $505.0 million in Q1 2026 for GE HealthCare Technologies, down from $821.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $834.0 million in Q4 2024 to a low of $505.0 million in Q1 2026.
  • Median EBT over the past 5 years was $622.0 million (2022), compared with a mean of $631.1 million.
  • Biggest five-year swings in EBT: soared 36.95% in 2024 and later fell 27.02% in 2026.
  • GE HealthCare Technologies' EBT stood at $718.0 million in 2022, then dropped by 15.18% to $609.0 million in 2023, then surged by 36.95% to $834.0 million in 2024, then fell by 1.56% to $821.0 million in 2025, then tumbled by 38.49% to $505.0 million in 2026.
  • The last three reported values for EBT were $505.0 million (Q1 2026), $821.0 million (Q4 2025), and $643.0 million (Q3 2025) per Business Quant data.